Tudor Investment Corp
RPTX

Tudor Investment Corp’s Repare Therapeutics RPTX Stock Holding History

Tudor Investment Corp’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,034
Closed -$251K – 2877
2022
Q4 		$251K Buy
+17,034
New +$255K 0.01% 2019
2022
Q2 		– Sell
-20,817
Closed -$296K – 2466
2022
Q1 		$296K Buy
+20,817
New +$309K 0.01% 1563
2021
Q1 		– Sell
-11,502
Closed -$395K – 1814
2020
Q4 		$395K Sell
11,502
-12,105
-51% -$362K 0.01% 1030
2020
Q3 		$726K Sell
23,607
-10,306
-30% -$273K 0.03% 679
2020
Q2 		$1.05M Buy
+33,913
New +$1.09M 0.05% 452

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tudor Investment Corp's RPTX Position: Q1 2023 in Review

Tudor Investment Corp sold out of Repare Therapeutics (RPTX) in Q1 2023, closing a stake of 17,034 shares — an estimated $251K sold.

Tudor Investment Corp first reported a position in RPTX in Q2 2020 and held it in 5 quarters. The position peaked at $1.05M in Q2 2020. 77 funds tracked by Wall St. Rank hold RPTX as of Q1 2023.

  • Tudor Investment Corp reported no remaining Repare Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 17,034 Repare Therapeutics shares in Q1 2023, an estimated $251K.
  • Tudor Investment Corp first reported a position in Repare Therapeutics in Q2 2020 and held it in 5 quarters.
  • Tudor Investment Corp's Repare Therapeutics position peaked at $1.05M in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2023.

Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.